Skip to main content
. Author manuscript; available in PMC: 2017 Nov 1.
Published in final edited form as: Am J Geriatr Psychiatry. 2016 Apr 11;24(11):1000–1003. doi: 10.1016/j.jagp.2016.03.006

Table 1.

States with dementia-related agitation as a qualifying condition for medical marijuana.

State (year of approval) Medical marijuana licenses for dementia-related agitation,
N (%a)
Arizona (2010) 33 (0.1)
Delaware (2011) 0 (0.0)
Illinois (2013) 7 (0.2)
Maine (1999) b
Maryland (2014) c
Michigan (2008) 48 (0.05)
New Hampshire (2013) b
Oregon (1998) b
Rhode Island (2006) 24 (0.1)
Washington, DC (2010) n/ad
a

% of state’s total licenses granted in 2014

b

No information by indication in 2014 annual report

c

Patient registration to begin in 2016

d

A qualifying condition is “any condition for which treatment with medical marijuana would be beneficial, as determined by the patient’s physician”; there are no specific qualifying conditions. (http://doh.dc.gov/sites/default/files/dc/sites/doh/publication/attachments/120430FAQPhysicians%20Final_0_0.pdf)